Detalles de la búsqueda
1.
Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Exp Dermatol
; 33(1): e14976, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946551
2.
Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial.
Br J Dermatol
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833158
3.
Neutrophil-to-lymphocyte ratio is associated with survival and sentinel lymph node positivity in invasive cutaneous squamous cell carcinoma: A retrospective study.
J Am Acad Dermatol
; 86(3): 615-620, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715284
4.
Management of elderly patients with advanced cutaneous squamous cell carcinoma.
Jpn J Clin Oncol
; 52(3): 214-220, 2022 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088087
5.
Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases.
Acta Derm Venereol
; 102: adv00756, 2022 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670329
6.
Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.
Cancer Sci
; 110(11): 3434-3441, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31509303
7.
Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.
BMC Cancer
; 19(1): 1019, 2019 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31664934
8.
A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Pathol Int
; 69(8): 496-501, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31276279
9.
Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results.
Br J Dermatol
; 189(4): 476-478, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243542
10.
Combined use of nivolumab and ipilimumab in Japanese patients with melanoma: a multicentre retrospective study of 111 cases.
Br J Dermatol
; 189(2): 223-250, 2023 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017027
11.
Nivolumab-induced thyroid dysfunction.
Jpn J Clin Oncol
; 46(6): 575-9, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27012985
12.
The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melanoma.
Acta Oncol
; 58(3): 379-381, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30614355
13.
Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.
J Dermatol
; 51(3): 458-462, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37518979
14.
Sentinel lymph node biopsy in extramammary Paget disease: A 13-year institutional experience.
J Dermatol
; 50(1): 57-63, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36217770
15.
Cutaneous angiosarcoma treated with taxane-based chemoradiotherapy: A multicenter study of 90 Japanese cases.
Skin Health Dis
; 3(1): e180, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36751323
16.
Treatment for taxane-resistant cutaneous angiosarcoma: A multicenter study of 50 Japanese cases.
J Dermatol
; 50(7): 912-916, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36938650
17.
Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter study.
J Dermatol Sci
; 110(1): 19-26, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37045720
18.
Systemic therapy for Asian patients with advanced BRAF V600-mutant melanoma in a real-world setting: A multi-center retrospective study in Japan (B-CHECK-RWD study).
Cancer Med
; 12(17): 17967-17980, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584204
19.
Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'.
Br J Cancer
; 116(8): e14, 2017 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28324884
20.
[II. The Latest Treatment Strategy of the Melanoma - The Actual Situation in Japan].
Gan To Kagaku Ryoho
; 44(4): 302-305, 2017 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-28428510